Hepatology Forum
Scope & Guideline
Advancing liver health through innovative research.
Introduction
Aims and Scopes
- Liver Disease Mechanisms and Pathophysiology:
Research exploring the underlying mechanisms of various liver diseases, including hepatitis, fatty liver diseases, and liver cancer, contributes to a deeper understanding of disease progression and management. - Transplantation and Surgical Interventions:
The journal emphasizes studies on liver transplantation, including donor selection, surgical techniques, and post-operative care, which are crucial for improving patient outcomes. - Innovative Diagnostic Approaches:
The publication covers advancements in diagnostic methodologies, such as imaging techniques and biomarker identification, enhancing the accuracy and efficiency of liver disease diagnoses. - Therapeutic Strategies and Clinical Trials:
A significant focus is placed on novel therapeutic interventions for liver diseases, including pharmacological treatments, dietary modifications, and alternative therapies, supported by clinical trial data. - Public Health and Epidemiology:
The journal addresses the epidemiological aspects of liver diseases, including prevalence studies and risk factor assessments, to inform public health strategies and resource allocation. - Genetic and Molecular Research:
Research investigating genetic predispositions and molecular pathways involved in liver diseases is a core area, contributing to personalized medicine approaches in hepatology.
Trending and Emerging
- Metabolic Dysfunction-Associated Liver Disease (MASLD):
Recent publications indicate a significant increase in research focused on metabolic dysfunction-associated liver disease, reflecting its rising prevalence and importance in the context of global health. - Artificial Intelligence in Hepatology:
The integration of artificial intelligence for predictive modeling and diagnostic purposes in liver disease management is gaining traction, highlighting a trend towards utilizing technology in clinical practice. - Impact of COVID-19 on Liver Health:
The exploration of COVID-19's effects on liver diseases, including complications and management strategies, has emerged as a critical area of research in light of the pandemic's ongoing impact. - Personalized Medicine and Genetic Studies:
There is a growing trend towards personalized medicine, with an emphasis on genetic studies that tailor treatment approaches based on individual patient profiles and genetic backgrounds. - Non-Invasive Assessment Techniques:
The rise of non-invasive techniques for assessing liver conditions, such as elastography and biochemical markers, reflects an emerging focus on improving patient comfort and clinical outcomes.
Declining or Waning
- Traditional Pharmaceutical Treatments:
There appears to be a waning focus on older, conventional pharmacological treatments for liver diseases, possibly due to the emergence of more effective and targeted therapies. - Basic Science Without Clinical Application:
Research that primarily explores basic science without clear clinical implications or applications is becoming less prominent, as the journal increasingly emphasizes translational research. - Case Reports of Rare Conditions:
While case reports provide valuable insights, the frequency of publications on rare liver conditions has diminished, likely as the journal prioritizes studies with broader clinical relevance.
Similar Journals
LIVER INTERNATIONAL
Shaping the future of hepatology with impactful discoveries.LIVER INTERNATIONAL, with its ISSN 1478-3223 and E-ISSN 1478-3231, is a prestigious peer-reviewed journal published by Wiley in the United Kingdom. Established in 2003, it focuses on advancing the field of hepatology, covering a broad spectrum of topics including liver disease, hepatocellular carcinoma, and transplantation. Ranking #10 out of 82 in the Scopus category for Medicine - Hepatology and boasting a remarkable 88th percentile, LIVER INTERNATIONAL has secured its reputation as a leading journal, recognized as Q1 in the 2023 category quartiles. The journal emphasizes accessibility, offering an open access option to ensure that critical research findings reach a wider audience. By facilitating the dissemination of high-quality research, LIVER INTERNATIONAL plays a vital role in shaping contemporary hepatological discourse and bridging academic inquiry with clinical practice, making it an essential resource for researchers, healthcare professionals, and students alike.
Expert Review of Gastroenterology & Hepatology
Innovating Treatments, Elevating Patient CareExpert Review of Gastroenterology & Hepatology is a premier journal published by Taylor & Francis Ltd that aims to bridge the gap between clinical practice and research in the fields of gastroenterology and hepatology. Established in 2007, this journal has rapidly gained recognition, boasting a Q1 ranking in Gastroenterology and a Q2 ranking in Hepatology for 2023, while achieving impressive Scopus rankings of 31st and 25th respectively in these disciplines, placing it within the top 81st and 70th percentiles. The journal’s objective is to provide a comprehensive platform for the latest developments, innovative treatments, and critical reviews, catering to researchers, healthcare professionals, and students alike. Located in the United Kingdom, the journal does not operate under an open access model but ensures that its content is accessible to a global audience through institutional subscriptions. By consistently publishing high-impact reviews and articles, Expert Review of Gastroenterology & Hepatology solidifies its role as a vital resource in advancing knowledge and clinical practice within these challenging and evolving fields.
Clinics in Liver Disease
Unveiling the complexities of hepatology for better care.Clinics in Liver Disease is an esteemed peer-reviewed journal published by W B Saunders Co-Elsevier Inc, dedicated to advancing the field of hepatology. Established in 1997 and covering a broad range of topics within liver disease research, this journal serves as a vital resource for researchers, clinicians, and students engaged in the study of liver health and diseases. With a commendable impact factor placing it within the Q2 category in Hepatology and ranking #32 out of 82 in the Scopus classifications, it consistently disseminates high-quality research and clinical insights. The journal’s commitment to promoting understanding and management of liver diseases is reflected in its rigorous editorial standards and comprehensive review processes. Although not an open-access publication, Clinics in Liver Disease offers subscription options that ensure accessibility to up-to-date research and reviews critical for both academic and clinical success.
Pediatric Gastroenterology Hepatology & Nutrition
Advancing pediatric health through innovative research.Pediatric Gastroenterology Hepatology & Nutrition is a pivotal academic journal published by the Korean Society of Pediatric Gastroenterology & Nutrition, focusing on the critical fields of pediatric gastroenterology, hepatology, and nutrition. Located in South Korea, this journal aims to disseminate high-quality research, review articles, and clinical studies to advance knowledge and practice in the care of children with gastrointestinal and nutritional disorders. With a Converged Years span from 2012 to 2024 and categorized in the Q2 and Q3 quartiles in 2023 across multiple related fields, the journal holds a significant position within the academic community, reflecting its impactful contribution to the discipline. Although currently not open access, the journal ensures that content is accessible to a broad audience through various institutional subscriptions. The journal appeals to researchers, healthcare professionals, and students alike, providing an essential platform for the exchange of innovative ideas and research findings aimed at improving pediatric patient care.
Journal of Gastrointestinal and Liver Diseases
Driving Impactful Discoveries in Digestive HealthThe Journal of Gastrointestinal and Liver Diseases, published by MEDICAL UNIV PRESS in Romania, serves as a pivotal platform for the dissemination of significant research in the fields of gastroenterology and hepatology. Established in 2006, this journal has evolved over the years, currently holding a Q3 rank in Gastroenterology and a Q2 rank in Medicine (miscellaneous), reflecting its commitment to high-quality scholarship and impactful contributions to medical science.
With an ISSN of 1841-8724 and an E-ISSN of 1842-1121, the journal engages a diverse readership of researchers, clinicians, and students passionate about advancing knowledge in gastrointestinal and liver health. While it currently does not operate under an open access model, the journal remains a vital resource for those seeking to stay updated on the latest developments and emerging trends in the field. As it converges towards a broader impact, projected through its coverage until 2024, the Journal of Gastrointestinal and Liver Diseases continues to contribute to the academic landscape, encouraging innovation and comprehensive understanding in digestive health.
JHEP Reports
Driving excellence in gastroenterology and internal medicine.JHEP Reports, published by ELSEVIER, stands at the forefront of scholarly communication in the fields of Gastroenterology, Hepatology, Immunology and Allergy, and Internal Medicine. As an Open Access journal since 2019, it provides a platform for the dissemination of high-quality research findings, making vital information readily accessible to a global audience. With a commendable impact characterized by a Q1 category ranking across four medical disciplines in 2023, JHEP Reports demonstrates its significance and influence, reflected in its impressive Scopus ranks—#11 in Gastroenterology and #14 in Internal Medicine, amongst others. This esteemed journal not only plays a critical role in advancing knowledge but also fosters collaboration among researchers, practitioners, and students keen on exploring innovations and breakthroughs in health sciences. At RADARWEG 29, 1043 NX AMSTERDAM, NETHERLANDS, JHEP Reports is committed to bridging the gap between research and application, ushering in a new era of informed and effective healthcare solutions.
Clinical Gastroenterology and Hepatology
Exploring Breakthroughs in Liver and Gastrointestinal ResearchClinical Gastroenterology and Hepatology, published by Elsevier Science Inc, stands as a leading journal in the fields of gastroenterology and hepatology. With an ISSN of 1542-3565 and an E-ISSN of 1542-7714, this esteemed publication has earned its place in the top quartile (Q1) of both gastroenterology and hepatology categories as of 2023, ranking 6th out of 167 and 7th out of 82 respectively. The journal aims to disseminate innovative research, clinical studies, and case reports that advance the understanding and treatment of gastrointestinal and liver diseases. Targeted towards researchers, healthcare professionals, and students, it provides crucial insights into emerging therapies and medical advancements. Clinical Gastroenterology and Hepatology is not only a pivotal resource for contemporary gastroenterological research but also fosters collaboration and knowledge-sharing within the medical community. With a converging publication history from 2003 to the present, the journal continues to build on its solid foundation of scientific excellence and relevance.
HEPATOLOGY
Connecting experts to foster collaboration in hepatology.HEPATOLOGY is a premier scholarly journal dedicated to advancing the field of liver research and clinical practice. Published by Lippincott Williams & Wilkins, this journal boasts an impressive impact factor and holds a prestigious position as one of the top-ranked publications in both Hepatology (Q1) and Medicine (miscellaneous, Q1) categories as of 2023. HEPATOLOGY, with its commitment to disseminating high-quality research since its inception in 1981, serves as an essential platform for researchers, clinicians, and students focusing on liver diseases, including hepatitis, cirrhosis, and liver cancer. The journal's editorial board comprises leading experts who guide the publication towards its objective of fostering innovation and collaboration in this critical area of health. Although it does not offer an open access model, HEPATOLOGY ensures that its comprehensive analyses, reviews, and groundbreaking studies are accessible to the global medical community. Join the discourse in hepatology and be a part of a transformative journey through this indispensable resource.
International Journal of Hepatology
Bridging research and clinical practice in hepatology.The International Journal of Hepatology, published by HINDAWI LTD, is a premier open-access journal dedicated to the field of hepatology. Since its inception, this journal has championed the dissemination of cutting-edge research and reviews pertaining to liver health, diseases, and therapies. With an ISSN of 2090-3448, the journal has been committed to open-access publishing since 2011, ensuring that vital knowledge is readily available to researchers, clinicians, and students worldwide. Based in Egypt, this journal stands out in its category, achieving a Q3 ranking in 2023 within the scope of Hepatology by Scopus, which ranks it #43 out of 82 in the field. The International Journal of Hepatology offers a platform for significant findings and discussions that influence clinical practices and foster new research directions, thus playing a crucial role in advancing the understanding of liver diseases and their management.
Gastroenterologia y Hepatologia
Connecting scholars to the forefront of gastroenterology and hepatology.Gastroenterologia y Hepatologia, published by Elsevier España SLU, is a distinguished journal dedicated to advancing the fields of gastroenterology and hepatology. With a publication history spanning from 1982 to 2024, this journal is recognized for its commitment to disseminating high-quality research and reviews that address critical developments in the diagnosis and treatment of gastrointestinal and liver diseases. Although it currently ranks in the Q3 quartile in both gastroenterology and hepatology based on the 2023 metrics, the journal continues to attract a global audience of researchers, healthcare professionals, and students eager to engage with the latest findings. The journal is accessible in both print and electronic formats (ISSN: 0210-5705), making its valuable insights reachable to a broad spectrum of subscribers. By fostering a platform for rigorous scholarly communication, Gastroenterologia y Hepatologia plays a vital role in shaping the future of research in these essential medical fields.